SIMULTANEOUSLY BOTH EXPRESSION OF LMP-1
AND METHYLATION OF E-CADHERIN:
MOLECULAR BIOMARKER IN STAGE IV OF
NASOPHARYNGEAL CARCINOMA PATIENTS
Lao TD1, Truong PK1, Thieu HH1, Nguyen DH2, Nguyen MT3, Le TAH1,*
*Corresponding Author: Associate Professor Thuy A.H. Le, Department of Pharmaceutical and Medical
Biotechnology, Ho Chi Minh City Open University, 35-37 Ho Hao Hon Street, Ho Chi Minh City,
Vietnam. Tel.: +84-905-784-471. E-mail: thuy.lha@ou.edu.vn
page: 57
|
|
REFERENCES
1. Lao TD, Le TAH. MicroRNAs: Biogenesis, functions
and potential biomarkers for early screening,
prognosis and therapeutic molecular monitoring of
nasopharyngeal carcinoma. Processes. 2020; 8(8):
966-1009.
2. Tabuchi K, Nakayama M, Nishimura B, Hayashi K,
Hara A. Early detection of nasopharyngeal carcinoma.
Int J Otolaryngol. 2011; 2011: 638058.
3. Li M, Wang C, Yu B, Zhang X, Shi F, Liu X.
Diagnostic value of RASSF1A methylation for breast
cancer: A meta-analysis. Biosci Rep. 2019; 39(6):
BSR20190923.
4. Rowe M, Lear AL, Croom-Carter D, Davies AH,
Rickinson AB. Three pathways of Epstein-Barr virus
gene activation from EBNA1-positive latency in B
lymphocytes. J Virol. 1992; 66(1): 122-131.
5. Vera-Sempere FJ, Burgos JS, Botella MS, Cordoba
J, Gobernado M. Immunohistochemical expression
of Epstein-Barr virus-encoded latent membrane protein
(LMP-1) in paraffin sections of EBV-associated
nasopharyngeal carcinoma in Spanish patients. Eur
J Cancer B Oral Oncol. 1996; 32B(3): 163-168.
6. Young LS, Dawson CW, Eliopoulos AG. The expression
and function of Epstein-Barr virus encoded latent
genes. Mol Pathol. 2000; 53(5): 238-247.
7. Lao TD, Nguyen DH, Nguyen TM, Le TAH. Molecular
screening for Epstein-Barr virus (EBV): Detection of
genomic EBNA-1, EBNA-2, LMP-1, LMP-2 among
Vietnamese patients with nasopharyngeal brush samples.
Asian Pac J Cancer Prev. 2017; 18(6): 1675-1679.
8. Lao TD, Nguyen TAH, Ngo KD, Thieu HH, Nguyen
MT, Nguyen DH, et al. Molecular screening of nasopharyngeal
carcinoma: Detection of LMP-1, LMP-2
gene expression in Vietnamese nasopharyngeal swab
samples. Asian Pac J Cancer Prev. 2019; 20(9): 2757-
2761.
9. Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-
Traub N. Clonal proliferations of cells infected with
Epstein-Barr virus in preinvasive lesions related to
nasopharyngeal carcinoma. N Engl J Med. 1995;
333(11): 693-698.
10. Raab-Traub N. Epstein-Barr virus in the pathogenesis
of NPC. Semin Cancer Biol. 2002; 12(6): 431-441.
11. Zhao Y, Wang Y, Zeng S, Hu X. LMP1 expression
is positively associated with metastasis of nasopharyngeal
carcinoma: evidence from a meta-analysis.
J Clin Pathol. 2012; 65(1): 41-45.
12. Goodwin M, Yap AS. Classical cadherin adhesion
molecules: Coordinating cell adhesion, signaling and
the cytoskeleton. J Mol Histol. 2004; 35(9): 839-844.
13. Jeanes A, Gottardi CJ, Yap AS. Cadherins and cancer:
How does cadherin dysfunction promote tumor
progression? Oncogene. 2008; 27(55): 6920-6929.
14. Tsao SW, Liu Y, Wang XX, Yuen PW, Leung SY, Yuen
ST, et al. The association of E-cadherin expression
and the methylation status of the E-cadherin gene in
nasopharyngeal carcinoma cells. Eur J Cancer. 2003;
39(4): 524-531.
15. Niemhom S, Kitazawa S, Kitazawa R, Maeda S,
Leopairat J. Hypermethylation of epithelial-cadherin
gene promoter is associated with Epstein-Barr virus
in nasopharyngeal carcinoma. Cancer Detect Prev.
2008; 32(2): 127-134.
16. Ayadi W, Karray-Hakim H, Khabir A, Feki L, Charfi
S, Boudawara T, et al. Aberrant methylation of p16,
DLEC1, BLU and E-cadherin gene promoters in
nasopharyngeal carcinoma biopsies from Tunisian
patients. Anticancer Res. 2008; 28(4B): 2161-2167.
17. Ran Y, Wu S, You Y. Demethylation of E-cadherin
gene in nasopharyngeal carcinoma could serve as
a potential therapeutic strategy. J Biochem. 2011;
149(1): 49-54.
18. Ryan JL, Fan H, Glazer SL, Schichman SA, Raab-
Traub N, Gulley ML. Epstein-Barr virus quantitation
by real-time PCR targeting multiple gene segment: A novel approach to screen for the virus in paraffinembedded
tissue and plasma. J Mol Diagn. 2004;
6(4): 378-385.
19. Al-Mozaini M, Bodelon G, Karsstegl CE, Jin B, Al-
Ahdal M, Farrell PJ. Epstein-Barr virus BART gene
expression. J Gen Virol. 2009; 90(Pt 2): 307-316.
20. Banko A, Lazarevic I, Cupic M, Stevanovic G, Boricic
I, Jovanovic T. Carboxy-terminal sequence variation
of LMP1 gene in Epstein-Barr-virus-associated
mononucleosis and tumors from Serbian patients. J
Med Virol. 2012; 84(4): 632-642.
21. Dawson CW, Port RJ, Young LS. The role of the EBVencoded
latent membrane proteins LMP1 and LMP2
in the pathogenesis of nasopharyngeal carcinoma
(NPC). Semin Cancer Biol. 2012; 22(2): 144-153.
22. Hao SP, Tsang NM, Chang KP, Ueng SH. Molecular
diagnosis of nasopharyngeal carcinoma: Detecting
LMP-1 and EBNA by nasopharyngeal swab.
Otolaryngol Head Neck Surg. 2004; 131(5): 651-654.
23. See HS, Yap YY, Yip WK, Seow HF. Epstein-Barr
virus latent membrane protein-1 (LMP-1) 30-bp deletion
and Xho I-loss is associated with type III nasopharyngeal
carcinoma in Malaysia. World J Surg
Oncol. 2008; 6: 18-27.
24. Kang MS, Kieff E. Epstein-Barr virus latent genes.
Exp Mol Med. 2015; 47(1): e131-e146.
25. Li Z, Lin SX, Liang YJ. Influence of E-cadherin promoter
methylation and mutation of beta-catenin on invasion
and metastasis of nasopharyngeal carcinoma cells.
Zhonghua Zhong Liu Za Zhi. 2003; 25(3): 238-242.
26. Palmisano WA, Divine KK, Saccomanno G, Gilliland
FD, Baylin SB, Herman JG, et al. Predicting lung
cancer by detecting aberrant promoter methylation
in sputum. Cancer Res. 2000; 60(21): 5954-5958.
27. Lin SX, Zong YS, Chu B, Zhong BL, Li Z, Liang YJ,
et al. Relationship between the expressions of LMP-1
and e-cadherin/beta-catenin in nasopharyngeal carcinoma.
Chin J Cancer Res. 2002; 14(3): 202-205.
28. Qiu X, Qiao F, Su X, Zhao Z, Fan H. Epigenetic
activation of E-cadherin is a candidate therapeutic
target in human hepatocellular carcinoma. Exp Ther
Med. 2010; 1(3): 519-523.
29. Corso G, Bonanni B, Veronesi P. Tumor inactivation
of E-cadherin: A new tool for breast cancer treatment?
Ann Transl Med. 2018; 6(Suppl 1): S6.
30. Christman JK. 5-Azacytidine and 5-aza-2’-deoxycytidine
as inhibitors of DNA methylation: Mechanistic
studies and their implications for cancer therapy.
Oncogene. 2002; 21(35): 5483-5495.
31. Nam JS, Ino Y, Kanai Y, Sakamoto M, Hirohashi S.
5-Aza-2’-deoxycytidine restores the E-cadherin system
in E-cadherin-silenced cancer cells and reduces cancer
metastasis. Clin Exp Metastasis. 2004; 21(1): 49-56.
32. Hannigan A, Wilson JB. Evaluation of LMP1 of
Epstein-Barr virus as a therapeutic target by its inhibition.
Mol Cancer. 2010; 9: 184.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
